A detailed history of Man Group PLC transactions in Bioventus Inc. stock. As of the latest transaction made, Man Group PLC holds 24,998 shares of BVS stock, worth $278,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,998
Previous 112,906 77.86%
Holding current value
$278,977
Previous $587,000 75.64%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.96 - $6.93 $348,115 - $609,202
-87,908 Reduced 77.86%
24,998 $143,000
Q1 2024

May 15, 2024

BUY
$4.33 - $5.75 $187,194 - $248,584
43,232 Added 62.05%
112,906 $587,000
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $201,357 - $372,059
69,674 New
69,674 $367,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $688M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.